We are live on ! Find out more
GTC

Ghost Tree Capital Portfolio holdings

AUM $331M
1-Year Est. Return 70.11%
This Fund
S&P 500
This Quarter Est. Return
+23.45%
1 Year Est. Return
+70.11%
3 Year Est. Return
+265.05%
5 Year Est. Return
+3,034.98%
10 Year Est. Return
+22,104.75%
AUM
$208M
AUM Growth
+$24.2M
Cap. Flow
+$3.02M
Cap. Flow %
1.45%
Top 10 Hldgs %
36.52%
Holding
103
New
33
Increased
10
Reduced
10
Closed
44

Top Buys

Rank Stock Value
1
WMGI
Wright Medical Group Inc
WMGI
+$6.88M
2
GILD icon
Gilead Sciences
GILD
+$6.72M
3
PBYI icon
Puma Biotechnology
PBYI
+$5.55M
4
CPHD
Cepheid Inc
CPHD
+$5.06M
5
AVDL
Avadel Pharmaceuticals
AVDL
+$4.64M

Top Sells

Rank Stock Value
1
CYH icon
Community Health Systems
CYH
+$5.48M
2
TRNX
TORNIER N V SHARES (NLD)
TRNX
+$4.78M
3
VRTX icon
Vertex Pharmaceuticals
VRTX
+$4.49M
4
AGN
Allergan Inc
AGN
+$4.46M
5
HCA icon
HCA Healthcare
HCA
+$4.23M

Sector Composition

Rank Sector Weight
1 Healthcare 69%
2 Technology 1.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SNN icon
51
Smith & Nephew
SNN
$13.2B
$1.1M 0.53%
30,000
-7,500
-20% -$252K
ASPX
52
DELISTED
AUSPEX PHARMACEUTICALS INC COM STK (DE)
ASPX
$1.05M 0.5%
+20,000
New +$587K
OCRX
53
DELISTED
Ocera Therapeutics, Inc.
OCRX
$796K 0.38%
125,000
– –
BIOL
54
DELISTED
Biolase, Inc.
BIOL
$789K 0.38%
24
– –
EIGR
55
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$781K 0.37%
+89
New +$517K
CPRX
56
DELISTED
Catalyst Pharmaceutical
CPRX
$743K 0.36%
+250,000
New +$686K
ASMB icon
57
Assembly Biosciences
ASMB
$512M
$511K 0.25%
5,417
– –
GBIM
58
DELISTED
GLOBEIMMUNE INC COM STK (DE)
GBIM
$178K 0.09%
+23,500
New +$164K
A icon
59
CALL
Agilent Technologies
A
$38.4B
– –
-139,800
Closed -$5.7M
ABBV icon
60
CALL
AbbVie
ABBV
$449B
– –
-100,000
Closed -$5.78M
AGIO icon
61
Agios Pharmaceuticals
AGIO
$2.3B
– –
-20,000
Closed -$1.23M
AMRN
62
Amarin Corp
AMRN
$297M
– –
-10,000
Closed -$218K
ARCT icon
63
CALL
Arcturus Therapeutics
ARCT
$176M
– –
-7,143
Closed -$772K
BHC icon
64
CALL
Bausch Health
BHC
$1.84B
– –
-50,000
Closed -$6.56M
BMY icon
65
CALL
Bristol-Myers Squibb
BMY
$124B
– –
-200,000
Closed -$10.2M
BRKR icon
66
Bruker
BRKR
$9.02B
– –
-140,000
Closed -$2.59M
CPRX
67
PUT
DELISTED
Catalyst Pharmaceutical
CPRX
– –
-100,000
Closed -$332K
CYH icon
68
Community Health Systems
CYH
$476M
– –
-121,000
Closed -$5.48M
ENTA icon
69
Enanta Pharmaceuticals
ENTA
$384M
– –
-35,000
Closed -$1.39M
EW icon
70
Edwards Lifesciences
EW
$50.6B
– –
-150,000
Closed -$2.55M
EXAS
71
DELISTED
Exact Sciences
EXAS
– –
-125,000
Closed -$2.42M
EYPT icon
72
EyePoint Inc
EYPT
$1.09B
– –
-10,000
Closed -$442K
HCA icon
73
HCA Healthcare
HCA
$85.6B
– –
-60,000
Closed -$4.23M
HRTX icon
74
Heron Therapeutics
HRTX
$90.1M
– –
-70,000
Closed -$583K
LPCN icon
75
Lipocine
LPCN
$18.9M
– –
-5,398
Closed -$561K
1 2
3
4 5

Similar funds

SF
Susquehanna Foundation Bala Cynwyd, Pennsylvania $333M AUM 35.73% 1-Year Est. Return
AFS
Annapolis Financial Services Annapolis, Maryland $338M AUM 23.49% 1-Year Est. Return
SFA
Source Financial Advisors New York $338M AUM 33.62% 1-Year Est. Return
E
ETFidea Syracuse, New York $316M AUM 29.57% 1-Year Est. Return
OHCM
Oak Hill Capital Management New York $310M AUM 17.23% 1-Year Est. Return
MC
Minot Capital Broomfield, Colorado $353M AUM 25.25% 1-Year Est. Return
BRA
Biechele Royce Advisors Fishers, Indiana $303M AUM 20.64% 1-Year Est. Return
S
Syntrinsic Denver, Colorado $301M AUM 27.27% 1-Year Est. Return

Ghost Tree Capital's Q4 2014 Portfolio in Review

As of Q4 2014, Ghost Tree Capital held 103 positions worth $208M, up 13% from $184M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Ghost Tree Capital's Q4 2014 filing shows 33 new, 10 increased, 10 reduced and 44 closed positions. Its largest new stake was Wright Medical Group Inc: 235,000 shares worth $6.31M. The largest sale was Community Health Systems, an estimated $5.48M.

By sector, the portfolio is most concentrated in Healthcare at 69% of assets, up from 63% a quarter earlier, followed by Technology.

  • Ghost Tree Capital's largest Q4 2014 buy was Wright Medical Group Inc: 235,000 shares worth $6.31M.
  • Ghost Tree Capital added most to Puma Biotechnology in Q4 2014, an estimated $5.55M increase.
  • Ghost Tree Capital's biggest Q4 2014 reduction was AtriCure, cutting an estimated $2.57M.
  • Ghost Tree Capital fully exited Community Health Systems in Q4 2014, selling an estimated $5.48M.
  • Ghost Tree Capital's ten largest holdings make up 37% of its $208M portfolio in Q4 2014.
  • Ghost Tree Capital opened 33 new positions and closed 44 in Q4 2014.
  • Ghost Tree Capital's portfolio value rose 13% quarter-over-quarter to $208M.

Based on Ghost Tree Capital's 13F filing for Q4 2014, filed 17 Feb 2015.